| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 127,408 shares worth roughly $546K on balance. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $23.67M | -50,000 | |
| CEO | 2.07M | $8.03M | - | |
| Dir | 1.48M | $5.72M | - | |
| CFO | 1.07M | $4.15M | - | |
| Other | 1.04M | $4.04M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2021 | Dean Y Li78 | Director | Sell | 15,900 | $20.48 | $325,630.39 | -1.2% | -65.8% | -55.0% | |
| Dec 7, 2021 | Blake Borgeson68 | Director | Sell | 9,625 | $20.32 | $195,533.45 | -0.1% | -65.8% | -55.0% | |
| Dec 7, 2021 | Christopher Gibson71 | Chief Executive Officer | Sell | 19,792 | $20.48 | $405,432.76 | -11.9% | -65.8% | -55.0% | |
| Nov 19, 2021 | Dean Y Li78 | Director | Sell | 19,100 | $20.16 | $384,962.04 | -3.2% | -46.3% | -50.4% | |
| Nov 18, 2021 | Tina Marriott Larson73 | President and COO | Sell | 2,500 | $18.92 | $47,307.92 | -4.8% | -39.6% | -48.9% | |
| Nov 18, 2021 | Blake Borgeson68 | Director | Sell | 9,625 | $18.91 | $182,005.12 | -0.1% | -39.6% | -48.9% | |
| Apr 16, 2021 | Mubadala Investment Co Pjsc62 | 10% Owner | Buy | 2,777,777 | $18.00 | $49,999,986.00 | New | +3.8% | -79.1% | |
| Apr 16, 2021 | Lux Ventures IV, L.P. | 10% Owner | Buy | 100,000 | $18.00 | $1,800,000.00 | New | +3.8% | -79.1% |